[go: up one dir, main page]

GB201904555D0 - Biomarkers and uses thereof - Google Patents

Biomarkers and uses thereof

Info

Publication number
GB201904555D0
GB201904555D0 GBGB1904555.8A GB201904555A GB201904555D0 GB 201904555 D0 GB201904555 D0 GB 201904555D0 GB 201904555 A GB201904555 A GB 201904555A GB 201904555 D0 GB201904555 D0 GB 201904555D0
Authority
GB
United Kingdom
Prior art keywords
biomarkers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1904555.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manchester
Original Assignee
University of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Manchester filed Critical University of Manchester
Priority to GBGB1904555.8A priority Critical patent/GB201904555D0/en
Publication of GB201904555D0 publication Critical patent/GB201904555D0/en
Priority to PCT/GB2020/050860 priority patent/WO2020201742A1/en
Ceased legal-status Critical Current

Links

GBGB1904555.8A 2019-04-01 2019-04-01 Biomarkers and uses thereof Ceased GB201904555D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1904555.8A GB201904555D0 (en) 2019-04-01 2019-04-01 Biomarkers and uses thereof
PCT/GB2020/050860 WO2020201742A1 (en) 2019-04-01 2020-03-31 Biomarkers and uses thereof to stratify melanoma patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1904555.8A GB201904555D0 (en) 2019-04-01 2019-04-01 Biomarkers and uses thereof

Publications (1)

Publication Number Publication Date
GB201904555D0 true GB201904555D0 (en) 2019-05-15

Family

ID=66442868

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1904555.8A Ceased GB201904555D0 (en) 2019-04-01 2019-04-01 Biomarkers and uses thereof

Country Status (2)

Country Link
GB (1) GB201904555D0 (en)
WO (1) WO2020201742A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109476731A (en) * 2016-02-29 2019-03-15 基础医药有限公司 Methods of treating cancer
SG10202110594UA (en) * 2017-03-31 2021-11-29 Bristol Myers Squibb Co Methods of treating tumor

Also Published As

Publication number Publication date
WO2020201742A1 (en) 2020-10-08

Similar Documents

Publication Publication Date Title
ZA201908301B (en) Biomarkers and uses thereof
IL294052B1 (en) Fluoroalkyl-oxadiazoles and uses thereof
IL279458A (en) Neoantigens and uses thereof
IL285177A (en) Compounds and uses thereof
IL286497A (en) Compounds and uses thereof
IL289585A (en) Dll3-targeting antibodies and uses thereof
SG11202108079RA (en) Compounds and uses thereof
IL287503A (en) Thiosemicarbazates and uses thereof
IL291499A (en) Aza-quinoline compounds and uses thereof
GB201812561D0 (en) Biomarkers and uses thereof
IL284764A (en) Compounds and uses thereof
GB201806042D0 (en) Biomarkers and uses thereof
GB201902077D0 (en) Biomarkers
GB201900677D0 (en) Biomarkers
GB201902590D0 (en) Antibodies and uses thereof
ZA202201239B (en) Aminothiolester compounds and uses thereof
GB201819125D0 (en) Biomarkers and uses thereof
IL288807A (en) Anti-talen antibodies and uses thereof
IL280369A (en) New myokines and uses thereof
GB202001570D0 (en) Biomarkers and uses thereof
GB201708741D0 (en) Biomarkers and uses thereof
GB201904555D0 (en) Biomarkers and uses thereof
IL304313A (en) Novel biomarkers and uses thereof
GB201915228D0 (en) Biomarkers
IL286285A (en) Vista-binding antibodies and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)